Platelet aggregation test with measles antigen in multiple sclerosis

Area of Science:

• Neurology
• Immunology
• Virology

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• The potential role of viral infections, particularly measles, in MS pathogenesis remains an area of active research.
• Accurate serological methods are crucial for investigating such associations.

Purpose of the Study:

• To evaluate a novel measles platelet aggregation test for measles virus antibody detection.
• To compare measles antibody prevalence in patients with multiple sclerosis (MS) versus healthy controls.

Main Methods:

• A newly developed measles platelet aggregation test was utilized.
• Serum specimens from 153 MS patients and 164 controls were analyzed.
• Three different measles antigens were employed in the serological assay.

Main Results:

• A significantly higher positive rate (40%) for measles antibody was observed in MS patients compared to controls (11%) using one specific measles antigen (P<0.001).
• The remaining two measles antigens showed non-significantly higher positive rates in the MS cohort.
• The measles platelet aggregation test demonstrated potential utility in differentiating antibody levels between groups.

Conclusions:

• The study identifies a statistically significant association between elevated measles antibody levels and multiple sclerosis.
• The findings support the hypothesis of a potential link between measles virus and MS.
• The measles platelet aggregation test is a promising tool for further research into virus-antibody associations in neurological diseases.